Significant negative changes in fundamentals have recently occurred for Information Services Group Inc (NASDAQ: III): the consensus estimate for December, 2023 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 […]
Stock Rating Downgrade The Value Trend Rating for inTest Corp (NYSEAMERICAN: INTT) fell significantly of late from C to F reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in […]
Illumina Inc (NASDAQ: ILMN) has reported E.P.S. of $-4.77 for its third fiscal quarter (ending September 30) versus $-24.26 for the same period a year ago. This performance was $-4.91 short of the consensus estimate […]
On 11/9/23, EDAP TMS SA (NASDAQ: EDAP) stock suffered a major decline of -26.9%, closing at $5.26. The stock has been extremely weak relative to the market over the last nine months and has declined […]
Synaptics Inc (NASDAQ: SYNA) has reported a loss for its first fiscal quarter (ending September 30) of $-1.43 versus $1.62 for the same period a year ago — a decline of -188%. This result fell […]
For its third fiscal quarter (ending September 30), Harte Hanks Inc. (NASDAQ: HHS) has reported a -90% decline in E.P.S. from $0.87 a year ago to $0.09 in the current quarter. This performance was $-0.09 […]
Recent notable negative changes in fundamentals have impacted Ceva Inc (NASDAQ: CEVA): the consensus estimate for December, 2023 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased significantly. Recent […]
Sportsmans Warehouse Holdings In (NASDAQ: SPWH) stock closed at $4.40 on 11/9/23 after a major decline of -12.0%. The stock has been extremely weak relative to the market over the last nine months and has […]
Revance Therapeutics Inc (NASDAQ: RVNC) stock suffered a major decline of -17.0% on 11/9/23. The shares closed at $6.91. The stock has been extremely weak relative to the market over the last nine months and […]
Amicus Therapeutics Inc (NASDAQ: FOLD) stock suffered a major decline of -12.2% on 11/9/23. The shares closed at $9.98. The stock has been strong relative to the market over the last nine months but has […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research